Quantcast
Channel: CommonHealth
Viewing all articles
Browse latest Browse all 2224

The FDA Is Reviewing Biogen's 'Breakthrough' Alzheimer's Treatment

$
0
0

Currently, the only drugs available to Alzheimer’s patients are ones that delay symptoms. But aducanumab promises to alter the course of the disease.


Viewing all articles
Browse latest Browse all 2224

Trending Articles